Pharmaceutical Management: Our Impact

The MedSource Sales and Marketing team.

MedSource—a company dedicated to improving the availability and affordability of medicines and supplies—shared its work and vision with delegates at the 8th East Africa Healthcare Federation (EAHF) Conference last week.

The US Ambassador to Uganda, H.E. Deborah Malac, handed the facilities over to the Ministry of Health, represented by Dr. Charles Olaro, the Director of Clinical Services, at a ceremony at Luwunga Health Centre in Wakiso district.

On Thursday, August 22, 2019, the US Government officially handed over the first 14 of 26 newly constructed, prefabricated medicine storage units to the Ugandan Ministry of Health to help scale up the country’s HIV and AIDS epidemic response.The facilities will increase storage space for health commodities, including antiretroviral medicines, and will support the roll-out of the test and treat strategy for achieving HIV and AIDS control. The facilities will help ensure that adequate quantities of HIV medicines are available for Ugandans living with HIV.Dr.

Nancy Ngum and Paul Tanui (AUDA-NEPAD), Ms. Mimi Darko (Ghana FDA), and Kate Kikule (MTaPS)

Regional regulatory leaders, representatives from academia, and development organizations gathered in Accra, Ghana, in June to review a new monitoring and evaluation (M&E) tool that promises to improve access to safe, affordable medicines in several African countries by measuring the performance of Regional Centres of Regulatory Excellence (RCOREs).The African Union Development Agency (AUDA-NEPAD), in collaboration with the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) program, supported the validation of the M&E tool.

{Photo credit: Warren Zelman}Photo credit: Warren Zelman

What is the purpose of the USAID-funded Medicines, Technologies, and Pharmaceuticals Services (MTaPS) program, and what will the program accomplish?MTaPS recently published a collection of brief publications that provide information on the program’s objectives and planned activities.

 {Photo credit: Igor Dashevskiy}Deputy Minister of Health, Dr Roman Illyk, presents during the National Health Technology Assessment Forum in Kyiv, Ukraine.Photo credit: Igor Dashevskiy

A health technology assessment (HTA) is an evidence-based instrument to identify which medicines, medical devices, and treatment regimens are optimal for the state to support. It significantly reduces opportunities for corruption and helps countries move toward self-reliance in the health sector. A National Health Technology Assessment Forum took place in Kyiv, Ukraine, on February 28, 2019, to further advance HTA as an important priority-setting tool for Ukraine’s health system. Photo credit: Igor Dashevskiy

Principal Dispenser and MTC Secretary, David Ouma in the Moroto regional referral hospital medicines stores

Malaria is the leading cause of outpatient visits in Uganda (Ministry of Health, Annual Health Sector Performance Report, 2015/2016), and prevention, diagnosis, and treatment are crucial for reducing preventable deaths, lowering the risk of resistance to antimalarial medicines, and decreasing medicine wastage and misuse. 

On May 21, during the 71st World Health Assembly, member states adopted a new digital health resolution. It urges member states to better utilize digital technologies as a means of promoting equitable, affordable universal health coverage (UHC), including reaching vulnerable populations. The resolution also calls on members to analyze the implications of digital health to achieve health related sustainable development goals.

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

{Photo Credit: Wezi Tjaronda}Olavi Shomongula shares his testimony with U.S. Ambassador to Namibia Thomas F. Daughton.Photo Credit: Wezi Tjaronda

A new electronic health tool developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, implemented byMSH, is being used in more than 50 public health facilities in Namibia. This tool—the Facility Electronic Stock Card (FESC)—has noticeably expedited the dispensing of medication to patients. This was evident when the US Ambassador to Namibia H.E. Thomas F. Daughton visited the Intermediate Hospital Oshakati (IHO), which is in the populous Oshana region in the North-Central part of Namibia.

Pages